Grant

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

CountryUnited States
Deadline2028-11-05 (714 days left)
Published2024-12-30
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-25-362. CFDA: 93.865

The buyer, the value, the full description and the link to the official notice are available with a free account.